𝛼SK or Search

ENTITY

Exelixis Inc (EXEL US)

30

Analysis

Health Care • United States

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.

more

Refresh

Exchange Announcement • 11 Sep 2026 19:00

Current Report (Form 8-K | Period ending 2026-09-10)

Exchange Announcement • 05 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-07-03)

Exchange Announcement • 30 May 2026 04:05

Current Report (Form 8-K | Period ending 2026-05-26)

Exchange Announcement • 06 May 2026 04:07

Current Report (Form 8-K | Period ending 2026-05-05)

Exchange Announcement • 05 May 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-04-03)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x